Partnership will develop and validate unique in vitro/in silico models for oral cavity products Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that, through a joint proposal with the St. Louis College of Pharmacy at University of Health Sciences and […]
ANN ARBOR, MI—The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. Tauopathies are a group of neurodegenerative disorders sharing a common pathology […]
Expanded testing for toxins generated by harmful algal blooms in freshwater and shellfish to reduce testing burden on the aquaculture industry and improve the safety of the nation’s water and food supply. BOULDER, CO – MBio Diagnostics today announced receipt of two three-year NOAA/NCCOS PCMHAB awards for test menu expansion of its HAB Toxin System. […]
SEATTLE — Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of two NIH grants totaling $3.9M. The funds will be utilized to develop new, highly-scalable methods for detecting chromosomal rearrangements in diverse human samples. The adaptation of high-throughput proximity ligation (Hi-C) technology to cytogenomics promises to […]
Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader Company demonstrates solidity of its business model with banks joining in the […]
ATLANTA — Lucid Scientific, the biotechnology tools company that develops and manufactures RESIPHER, announced the completion of a $3 million Series Seed financing led by Dynamk Capital. Additional participants include Lucid’s original investor base and the Georgia Research Alliance’s Venture Fund, bringing Lucid’s total funding to date to approximately $4.5 million. Proceeds from this round will help the company aggressively expand production, […]
Proceeds will be used for the further development and deployment of IONpath’s revolutionary MIBI technology, affirming its leadership in high-definition spatial proteomics MENLO PARK, Calif. — IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million Series B financing led by Samsara BioCapital, and included participation from new investor […]
— PrognomIQ to develop multi-omics tests leveraging Seer’s Proteograph product — — Seer to retain minority ownership in PrognomIQ — Redwood City, CA — Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced that it has spun out and completed […]
Dräger Safety AG & Co. KGaA today announced that after an initial investment in the company in 2018, it has now made a follow-on equity investment in Kuva Systems. The Kuva platform is a camera-based methane monitoring solution centered on color-coded video clips of invisible gas that are automatically generated when emission events are detected. […]
Ansa Biotechnologies today announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Combined with a Pre-Seed round raised in December 2018 led by Fifty Years, the company has raised $9.2 million to date. The new investment […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
